Patent Foramen Ovale-associated Stroke and COVID-19 Vaccination
Stroke
Paresis
DOI:
10.15420/icr.2022.27
Publication Date:
2023-04-05T11:43:39Z
AUTHORS (4)
ABSTRACT
Background: COVID-19 infection has been associated with paradoxical thromboembolism through a patent foramen ovale (PFO) and ischaemic stroke. Such events have not reported after vaccination. The aim of the present study was to investigate PFO-associated stroke during mass vaccination in Slovenia. Methods: This prospective study, conducted between 26 December 2020 31 March 2022, enrolled consecutive patients (≥18 years) referred for percutaneous closure single interventional facility Results: A total 953,546 people aged 18 70 years received at least one dose vaccine approved by European Medicines Agency. Of 28 presenting stroke, 12 (42.9%) were vaccinated prior event, whom nine women three men, 21 years. Stroke occurred within 35 days six (50%). Clinical presentation included motor dysphasia, paresis, vertigo, ataxia, paraesthesia, headache, diplopia hemianopia. At hospital discharge, 11 (91.6%) had residual lesion. Conclusion: temporal coincidence described. potential cause–effect relationship may only be hypothesised.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (17)
CITATIONS (2)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....